Isabelle Delorme

690 total citations
14 papers, 228 citations indexed

About

Isabelle Delorme is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Isabelle Delorme has authored 14 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 6 papers in Immunology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Isabelle Delorme's work include Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Isabelle Delorme is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (6 papers) and Autoimmune Bullous Skin Diseases (4 papers). Isabelle Delorme collaborates with scholars based in Canada, United States and France. Isabelle Delorme's co-authors include Charles Lynde, Robert Bissonnette, Melinda Gooderham, Marie‐Claude Guertin, Juana Gonzalez, Catherine Maari, François Harel, Jean‐Claude Tardif, Malorie Chabot-Blanchet and James G. Krueger and has published in prestigious journals such as Journal of Investigative Dermatology, Journal of the American Academy of Dermatology and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Isabelle Delorme

10 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Delorme Canada 6 157 117 91 41 35 14 228
Niccolò Siliquini Italy 8 157 1.0× 121 1.0× 36 0.4× 33 0.8× 21 0.6× 18 196
Kristina Hagenström Germany 9 135 0.9× 44 0.4× 74 0.8× 41 1.0× 38 1.1× 37 219
David Pontes United States 6 137 0.9× 22 0.2× 64 0.7× 41 1.0× 22 0.6× 6 208
Susumu Kitamura Japan 6 132 0.8× 146 1.2× 24 0.3× 17 0.4× 63 1.8× 6 220
Л. С. Круглова Russia 5 110 0.7× 64 0.5× 19 0.2× 16 0.4× 30 0.9× 181 197
Kevin T. Savage United States 10 260 1.7× 27 0.2× 125 1.4× 71 1.7× 69 2.0× 17 299
V. Pallure France 6 62 0.4× 53 0.5× 20 0.2× 16 0.4× 20 0.6× 18 110
Xavier Cubiró Spain 9 66 0.4× 30 0.3× 43 0.5× 29 0.7× 33 0.9× 20 147
Caterina Cariti Italy 6 92 0.6× 102 0.9× 15 0.2× 21 0.5× 13 0.4× 11 161
Michela Tabanelli Italy 7 206 1.3× 36 0.3× 30 0.3× 12 0.3× 31 0.9× 20 285

Countries citing papers authored by Isabelle Delorme

Since Specialization
Citations

This map shows the geographic impact of Isabelle Delorme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Delorme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Delorme more than expected).

Fields of papers citing papers by Isabelle Delorme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Delorme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Delorme. The network helps show where Isabelle Delorme may publish in the future.

Co-authorship network of co-authors of Isabelle Delorme

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Delorme. A scholar is included among the top collaborators of Isabelle Delorme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Delorme. Isabelle Delorme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Albrecht, Lorne, Jennifer Beecker, Isabelle Delorme, et al.. (2024). 53822 Longitudinal evaluation of the psoriasis epidemiology screening tool (PEST) in patients with moderate to severe psoriasis: Results from the PURE Registry. Journal of the American Academy of Dermatology. 91(3). AB250–AB250.
3.
Papp, Kim, Melinda Gooderham, Charles Lynde, et al.. (2024). Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry. Archives of Dermatological Research. 316(7). 362–362. 1 indexed citations
4.
Metelitsa, Andrei I., et al.. (2023). A Practical Guide to Advanced Topical Drug Delivery Systems in Dermatology.. PubMed. 28(5). 5–11. 1 indexed citations
5.
Delorme, Isabelle. (2023). Marianne Hirsch, The Generation of Postmemory, Writing and Visual Culture after the Holocaust. Histoire Politique. 2 indexed citations
6.
Alhusayen, Raed, et al.. (2022). Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update. Journal of Cutaneous Medicine and Surgery. 26(2_suppl). 2S–24S. 11 indexed citations
7.
Gooderham, Melinda, Kim Papp, Charles Lynde, et al.. (2022). Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry. Dermatology and Therapy. 13(2). 535–553. 1 indexed citations
8.
Lynde, Charles, Yves Poulin, Jerry Tan, et al.. (2022). Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis. Journal of Drugs in Dermatology. 21(10). 1091–1097.
9.
Papp, Kim, Melinda Gooderham, Jennifer Beecker, et al.. (2019). Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America. BMC Dermatology. 19(1). 9–9. 7 indexed citations
10.
Zouboulis, Christos C., Hendrik H.G. Hansen, Raffaele Dante Caposiena, et al.. (2019). Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa. Dermatology. 236(1). 25–30. 51 indexed citations
11.
Delorme, Isabelle. (2019). L’échappée belle du roman graphique dans l’édition française. Sociétés & Représentations. N° 48(2). 195–216.
12.
Bissonnette, Robert, François Harel, James G. Krueger, et al.. (2017). TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study. Journal of Investigative Dermatology. 137(8). 1638–1645. 74 indexed citations
13.
Bissonnette, Robert, Richard P. Haydey, Charles Lynde, et al.. (2017). Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study. Journal of the European Academy of Dermatology and Venereology. 32(3). 403–410. 40 indexed citations
14.
Alavi, Afsáneh, Charles Lynde, Raed Alhusayen, et al.. (2017). Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document. Journal of Cutaneous Medicine and Surgery. 21(6). 513–524. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026